NCT07067372

Clinical Study on the Safety and Efficacy of a New Magnetic Navigation Radiofrequency Ablation Catheter for Rapid Arrhythmia

Clinical Study on the Safety and Efficacy of FireMagic™ Magbot Ablation Catheter for Rapid Arrhythmia

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Shanghai MicroPort EP MedTech Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Clinical study on the safety and efficacy of FireMagic™ Magbot Ablation Catheter for rapid arrhythmia

Detailed description

Explore the safety and efficacy of ireMagic™ Magbot Ablation Catheter for rapid arrhythmia in clinical studies, establish standards for standardised catheter use after market launch, and provide evaluation indicators that meet the requirements for nationwide multi-centre promotion.

Conditions

• Rapid Arrhythmia
• PFA
• Symptomatic Supraventricular Tachycardia

Interventions

Type	Name	Description
DEVICE	FireMagic™ Magbot Ablation Catheter	All patients signed informed consent forms, enrolled in the trial, underwent surgical treatment for rapid arrhythmia using XX, and were discharged after follow-up data collection. The total duration for each subject is estimated to be approximately 7 days.

Timeline

• Start date: 2025-12-31
• Primary completion: 2025-12-31
• Completion: 2028-12-31
• First posted: 2025-07-16
• Last updated: 2025-07-16

Locations

1 site across 1 country: China